HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Yongjiang Yu
The People's Hospital of Tongliang District, China
UBE2A binding to WAC through the ATR/CHK1 axis facilitates DNA damage repair, resulting in PARP inhibitor resistance in ovarian cancer